About
Cognilum is an intelligent wearable medical device that combines therapeutic non-invasive brain stimulation, EEG sensors and a personalization platform. Cognilum will enable children to integrate into society, parents to receive a home- based cost-effective treatment while having a better quality of life, therapists to track progress and efficacy of existing interventions, and both payers and government to spend less money on special education and lifelong residential care.
What Founders say:
Katya Sverdlov
CEO & Co-Founder
"JelikaLite is excited to join the M7 community and to meet mentors and friends along the way. We are a medical device company, developing a non-invasive brain stimulation device for autistic children. We already received FDA breakthrough device designation, won the NSF SBIR Phase I award, ran 2 feasibility clinical trials and are now getting ready for a Pivotal trial. We are looking for help with fund-raising, AAP clinical guidelines, reimbursement, and commercialization."